Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Eur J Pharmacol ; 942: 175519, 2023 Mar 05.
Article in English | MEDLINE | ID: mdl-36682481

ABSTRACT

Although cisplatin is a key drug in cancer chemotherapy, it often causes sensory peripheral neuropathy, presenting as allodynia in the early stage and hypoalgesia in the serious stage. Chronotherapy has previously been shown to ameliorate cisplatin-induced peripheral neuropathy that was severe enough to cause hypoalgesia in rats. It also has adverse effects such as renal dysfunction and ototoxicity, which are induced by oxidative stress. Here, we show that oxidative stress causes severe cisplatin-induced peripheral neuropathy, and that differences in oxidative stress occur depending on the dosing time of cisplatin. Cisplatin was administered to rats at 5:00 or 17:00 every seven days for four weeks. The antioxidant agent, 1,3-Dimethylthiourea (DMTU), was administered before and after the administration of cisplatin. The hot plate test was used to assess hypoalgesia. Oxidative stress in the sciatic nerve was assessed from thiobarbituric acid reactive substances (TBARs) and superoxide dismutase (SOD) activity. Nerve apoptosis was analysed with qRT-PCR. We observed an increase in TBARs and a decrease in SOD activity with the development of cisplatin-induced hypoalgesia, which was ameliorated by DMTU treatment. Furthermore, differences in the dosing time of cisplatin caused differences in oxidative stress which were correlated with cisplatin-induced hypoalgesia. Severe oxidative stress caused cisplatin-induced hypoalgesia, and chronotherapy with cisplatin ameliorated hypoalgesia by reducing oxidative stress. In the future, chronotherapy with cisplatin may contribute to the treatment of cancer in humans.


Subject(s)
Cisplatin , Oxidative Stress , Peripheral Nervous System Diseases , Animals , Rats , Cisplatin/administration & dosage , Peripheral Nervous System Diseases/chemically induced , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances
2.
PLoS One ; 14(9): e0214037, 2019.
Article in English | MEDLINE | ID: mdl-31518346

ABSTRACT

Linezolid is an oxazolidinone antibiotic that effectively treats methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Since rifampicin induces other antibiotic effects, it is combined with linezolid in therapeutic regimes. However, linezolid blood concentrations are reduced by this combination, which increases the risk of the emergence of antibiotic-resistant bacteria. We herein demonstrated that the combination of linezolid with rifampicin inhibited its absorption and promoted its elimination, but not through microsomal enzymes. Our results indicate that the combination of linezolid with rifampicin reduces linezolid blood concentrations via metabolic enzymes.


Subject(s)
Antibiotics, Antitubercular/pharmacology , Linezolid/pharmacokinetics , Rifampin/pharmacology , Animals , Antibiotics, Antitubercular/pharmacokinetics , Cytochrome P-450 CYP3A/genetics , Cytochrome P-450 CYP3A/metabolism , Drug Interactions , Humans , Liver/metabolism , Male , Methicillin-Resistant Staphylococcus aureus/drug effects , Mice , Microbial Sensitivity Tests , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology
3.
Bioorg Med Chem ; 27(2): 265-277, 2019 01 15.
Article in English | MEDLINE | ID: mdl-30553626

ABSTRACT

A new class of topoisomerase I inhibitors containing the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one (abbreviated as BBPI) ring system have been developed based on structure-activity relationship studies of the cytotoxic marine alkaloid lamellarin D. The pentacyclic BBPI scaffold was constructed from N-tert-butoxycarbonylpyrrole by sequential and regioselective functionalization of the pyrrole core using directed lithiation, conventional electrophilic substitution, and palladium-catalyzed cross-coupling reactions. Further N-alkylation of the scaffold followed by selective deprotection of the O-isopropyl group produced a range of N-substituted BBPI derivatives. The BBPIs thus prepared exhibited potent topoisomerase I inhibitory activity in DNA relaxation assays. The activities of BBPIs were higher than those of lamellarin D and camptothecin; they showed potent and selective antiproliferative activity in the panel of 39 human cancer cell lines established by Japanese Foundation for Cancer Research. COMPARE analyses indicated that the inhibition patterns of the BBPIs correlated well with those of the known topoisomerase I inhibitors such as SN-38 and TAS-103. The water-soluble valine ester derivative exhibited antitumor activity in vivo against murine colon carcinoma colon 26. The activity was comparable to that of the approved anticancer agent irinotecan.


Subject(s)
Antineoplastic Agents/therapeutic use , Coumarins/therapeutic use , Indoles/therapeutic use , Topoisomerase I Inhibitors/therapeutic use , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cattle , Cell Line, Tumor , Cell Proliferation/drug effects , Colonic Neoplasms/drug therapy , Coumarins/chemical synthesis , Coumarins/chemistry , Coumarins/pharmacology , Drug Design , Drug Screening Assays, Antitumor , Humans , Indoles/chemical synthesis , Indoles/chemistry , Indoles/pharmacology , Male , Mice, Inbred BALB C , Molecular Structure , Structure-Activity Relationship , Topoisomerase I Inhibitors/chemical synthesis , Topoisomerase I Inhibitors/chemistry , Topoisomerase I Inhibitors/pharmacology
4.
Cancer Res ; 77(23): 6603-6613, 2017 12 01.
Article in English | MEDLINE | ID: mdl-29038345

ABSTRACT

Clock genes encoding transcription factors that regulate circadian rhythms may inform chronomodulated chemotherapy, where time-dependent dose alterations might affect drug efficacy and reduce side effects. For example, inhibiting the essential cystine transporter xCT with sulfasalazine induces growth arrest in cancer cells. Although the anticancer effects of sulfasalazine have been studied extensively, its effects on transcriptional control of xCT expression have not been studied. Here, we show that sulfasalazine administration during the period of increased xCT expression improves its anticancer effects and that the Clock gene itself induces xCT expression and regulates its circadian rhythm. Our findings highlight the clinical potential of chronomodulated chemotherapy and the importance of xCT-mediated transcriptional regulation in the utility of such strategies. Cancer Res; 77(23); 6603-13. ©2017 AACR.


Subject(s)
ARNTL Transcription Factors/genetics , Amino Acid Transport System y+/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Circadian Clocks/physiology , Drug Chronotherapy , Sulfasalazine/pharmacology , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Gene Expression Regulation , Male , Mice , Mice, Inbred BALB C , Mice, Inbred ICR , Organoplatinum Compounds/pharmacology , Oxaliplatin , RNA Interference , RNA, Small Interfering/genetics , Transcription, Genetic/genetics
5.
J Pharmacol Pharmacother ; 8(1): 8-13, 2017.
Article in English | MEDLINE | ID: mdl-28405130

ABSTRACT

OBJECTIVE: To investigate the relationship between renal function and linezolid (LZD)-induced thrombocytopenia and elucidate the underlying mechanism using a chronic renal disease (CRD) mouse model. MATERIALS AND METHODS: CRD was induced in 5-week-old male Institute of Cancer Research (ICR) mice by 5/6 nephrectomy. After this procedure, LZD (25 and 100 mg/kg) was administered intraperitoneally once every day for 28 days. Platelet counts, white blood cell (WBC) counts, and hematocrit (HCT) levels were measured every 7 days. 2-14C-thymidine (0.185 MBq) was administrated intravenously to LZD-administered mice to evaluate the thymidine uptake ability of bone marrow. RESULTS: Platelet counts were significantly lower in the LZD-administered CRD group than in the LZD-nonadministered groups at 14, 21, and 28 days (P < 0.05); however, these changes were not observed in LZD-administered mice with normal renal function, regardless of the duration of LZD administration. No significant changes were observed in WBC counts or HCT levels in any LZD-administered CRD mouse. Moreover, radioactive levels in bone marrow were not significantly different in each group. CONCLUSIONS: These results indicate that LZD-induced decreases in platelet counts were enhanced by renal impairment in vivo, suggesting that LZD-induced thrombocytopenia is not caused by nonimmune-mediated bone marrow suppression.

6.
BMC Cancer ; 16(1): 756, 2016 Sep 27.
Article in English | MEDLINE | ID: mdl-27678475

ABSTRACT

BACKGROUND: Although cis-diamminedichloro-platinum (CDDP) exhibits strong therapeutic effects in cancer chemotherapy, its adverse effects such as peripheral neuropathy, nephropathy, and vomiting are dose-limiting factors. Previous studies reported that chronotherapy decreased CDDP-induced nephropathy and vomiting. In the present study, we investigated the influence of dosing times on CDDP-induced peripheral neuropathy in rats. METHODS: CDDP (4 mg/kg) was administered intravenously at 5:00 or 17:00 every 7 days for 4 weeks to male Sprague-Dawley rats, and saline was given to the control group. To assess the dosing time dependency of peripheral neuropathy, von-Frey test and hot-plate test were performed. RESULTS: In order to estimate hypoalgesia, the hot-plate test was performed in rats administered CDDP weekly for 4 weeks. On day 28, the withdrawal latency to thermal stimulation was significantly prolonged in the 17:00-treated group than in the control and 5:00-treated groups. When the von-Frey test was performed to assess mechanical allodynia, the withdrawal threshold was significantly lower in the 5:00 and 17:00-treated groups than in the control group on day 6 after the first CDDP dose. The 5:00-treated group maintained allodynia throughout the experiment with the repeated administration of CDDP, whereas the 17:00-treated group deteriorated from allodynia to hypoalgesia. CONCLUSIONS: It was revealed that the severe of CDDP-induced peripheral neuropathy was inhibited in the 5:00-treated group, whereas CDDP-treated groups exhibited mechanical allodynia. These results suggested that the selection of an optimal dosing time ameliorated CDDP-induced peripheral neuropathy.

7.
J Biol Chem ; 291(13): 7017-28, 2016 Mar 25.
Article in English | MEDLINE | ID: mdl-26797126

ABSTRACT

Iron is an important biological catalyst and is critical for DNA synthesis during cell proliferation. Cellular iron uptake is enhanced in tumor cells to support increased DNA synthesis. Circadian variations in DNA synthesis and proliferation have been identified in tumor cells, but their relationship with intracellular iron levels is unclear. In this study, we identified a 24-h rhythm in iron regulatory protein 2 (IRP2) levels in colon-26 tumors implanted in mice. Our findings suggest that IRP2 regulates the 24-h rhythm of transferrin receptor 1 (Tfr1) mRNA expression post-transcriptionally, by binding to RNA stem-loop structures known as iron-response elements. We also found thatIrp2mRNA transcription is promoted by circadian clock genes, including brain and muscle Arnt-like 1 (BMAL1) and the circadian locomotor output cycles kaput (CLOCK) heterodimer. Moreover, growth in colon-26(Δ19) tumors expressing the clock-mutant protein (CLOCK(Δ19)) was low compared with that in wild-type colon-26 tumor. The time-dependent variation of cellular iron levels, and the proliferation rate in wild-type colon-26 tumor was decreased by CLOCK(Δ19)expression. Our findings suggest that circadian organization contributes to tumor cell proliferation by regulating iron metabolism in the tumor.


Subject(s)
Circadian Clocks/genetics , Colonic Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Iron Regulatory Protein 2/genetics , Iron/metabolism , Receptors, Transferrin/genetics , ARNTL Transcription Factors/genetics , ARNTL Transcription Factors/metabolism , Animals , CLOCK Proteins/deficiency , CLOCK Proteins/genetics , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Cell Line, Tumor , Colon/metabolism , Colon/pathology , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Gene Deletion , Humans , Iron Regulatory Protein 1/genetics , Iron Regulatory Protein 1/metabolism , Iron Regulatory Protein 2/metabolism , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolism , Protein Multimerization , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Transferrin/metabolism , Response Elements , Signal Transduction
8.
Chronobiol Int ; 31(4): 564-71, 2014 May.
Article in English | MEDLINE | ID: mdl-24517140

ABSTRACT

OBJECTIVE: Morning stiffness and plasma cytokine levels in rheumatoid arthritis (RA) patients exhibit 24-hour variations. Tumor necrosis factor-α (TNF-α) plays a central role in RA clinical conditions, including the invasion of inflammatory cells, destruction of cartilage, systemic inflammatory response and its levels show a 24-hour rhythm after the onset of RA. In this study, we investigated what cytokines and/or transcriptional factors are involved in the formation of 24-hour variations in TNF-α levels after the onset of RA using MRL/Mpj-Tnfrsf6(lpr) (MRL/lpr) mice. METHOD: Blood was drawn at six different times from MRL/lpr mice to measure cytokines, serum amyloid A (SAA), IgG rheumatoid factor (IgG-RF) and corticosterone levels. Cytokine and transcriptional factor levels at the different times were measured in 10- and/or 15-week-old MRL/lpr mice. The promoter activity of TNF-α by lymphotoxins (LTs) was investigated using a dual-luciferase assay. RESULTS: SAA and TNF-α concentrations clearly exhibited 24-hour rhythms with higher levels at the light phase and lower levels at the dark phase after RA crisis. The expression of LT-α and LT-ß showed significant 24-hour rhythms in 15-week-old MRL/lpr mice and the phases of LT-α and LT-ß levels were antiphase compared with that of TNF-α. AP-1 binding sites were found in LT-α and LT-ß promoter regions, and jun mRNA expression corresponded to LT-α and LT-ß levels. TNF-α promoter activity was decreased due to the co-transfection of LT-α and LT-ß. CONCLUSION: LT-α and LT-ß controls the 24-hour rhythm in TNF-α levels after the onset of RA in order to suppress TNF-α promoter activity.


Subject(s)
Arthritis, Rheumatoid/blood , Circadian Rhythm , Inflammation Mediators/blood , Tumor Necrosis Factor-alpha/blood , Animals , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Biomarkers/blood , Cells, Cultured , Disease Models, Animal , Down-Regulation , Lymphotoxin-alpha/blood , Lymphotoxin-beta/blood , Male , Mice, Inbred MRL lpr , Promoter Regions, Genetic , Serum Amyloid A Protein/metabolism , Time Factors , Transcription, Genetic , Transfection , Tumor Necrosis Factor-alpha/genetics
9.
Biochim Biophys Acta ; 1838(5): 1306-12, 2014 May.
Article in English | MEDLINE | ID: mdl-24434061

ABSTRACT

Betaine uptake is induced by hypertonic stress in a placental trophoblast cell line, and involvement of amino acid transport system A was proposed. Here, we aimed to identify the subtype(s) of system A that mediates hypertonicity-induced betaine uptake. Measurement of [(14)C]betaine uptake by HEK293 cells transiently transfected with human or rat sodium-coupled neutral amino acid transporters (SNATs), SNAT1, SNAT2 and SNAT4 revealed that only human and rat SNAT2 have betaine uptake activity. The Michaelis constants (Km) of betaine uptake by human and rat SNAT2 were estimated to be 5.3 mM and 4.6 mM, respectively. Betaine exclusively inhibited the uptake activity of SNAT2 among the rat system A subtypes. We found that rat SNAT1, SNAT2 and SNAT4 were expressed at the mRNA level under isotonic conditions, while expression of SNAT2 and SNAT4 was induced by hypertonicity in TR-TBT 18d-1 cells. Western blot analyses revealed that SNAT2 expression on plasma membrane of TR-TBT 18d-1 cells was more potently induced by hypertonicity than that in total cell lysate. Immunocytochemistry confirmed the induction of SNAT2 expression in TR-TBT 18d-1 cells exposed to hypertonic conditions and indicated that SNAT2 was localized on the plasma membrane in these cells. Our results indicate that SNAT2 transports betaine, and that tonicity-sensitive SNAT2 expression may be involved in regulation of betaine concentration in placental trophoblasts.


Subject(s)
Amino Acid Transport Systems/metabolism , Betaine/metabolism , Placenta/metabolism , Trophoblasts/metabolism , Amino Acid Transport System A/genetics , Amino Acid Transport System A/metabolism , Amino Acid Transport Systems/genetics , Animals , Biological Transport/genetics , Cell Line , Cell Membrane/genetics , Cell Membrane/metabolism , Female , HEK293 Cells , Humans , Pregnancy , RNA, Messenger/genetics , Rats
10.
Cancer Res ; 74(2): 543-51, 2014 Jan 15.
Article in English | MEDLINE | ID: mdl-24253377

ABSTRACT

Circadian clock systems regulate many biologic functions, including cell division and hormone secretion in mammals. In this study, we explored the effects of circadian control on the pivot cell growth regulatory mTOR, the activity of which is deregulated in tumor cells compared with normal cells. Specifically, we investigated whether the antitumor effect of an mTOR inhibitor could be improved by changing its dosing schedule in RenCa tumor-bearing mice. Active, phosphorylated mTOR displayed a 24-hour rhythm, and levels of total mTOR protein (but not mRNA) also showed a circadian rhythm in RenCa tumor masses. Through investigations of the oscillation mechanism for mTOR expression, we identified the ubiquitination factor Fbxw7 as an mTOR regulator that oscillated in its expression in a manner opposite from mTOR. Fbxw7 transcription was regulated by the circadian regulator D-site-binding protein. Notably, administration of the mTOR inhibitor everolimus during periods of elevated mTOR improved survival in tumor-bearing mice. Our findings demonstrate that the circadian oscillation of mTOR activity is regulated by circadian clock systems, which influence the antitumor effect of mTOR inhibitors.


Subject(s)
Carcinoma, Renal Cell/metabolism , Circadian Rhythm , Kidney Neoplasms/metabolism , TOR Serine-Threonine Kinases/metabolism , Ubiquitin/chemistry , Animals , Cell Line, Tumor , Cell Survival , Everolimus , F-Box Proteins/metabolism , F-Box-WD Repeat-Containing Protein 7 , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Immunosuppressive Agents/pharmacology , Male , Mice , Mice, Inbred BALB C , NIH 3T3 Cells , Neoplasm Transplantation , Oscillometry , Signal Transduction , Sirolimus/analogs & derivatives , Sirolimus/pharmacology , Time Factors , Ubiquitin-Protein Ligases/metabolism
11.
Nihon Rinsho ; 71(12): 2200-5, 2013 Dec.
Article in Japanese | MEDLINE | ID: mdl-24437279

ABSTRACT

Transferrin receptor 1(TfR1) is a key cell surface molecule that regulates the uptake of iron-bound transferrin. TfR1 expression is higher in tumor cells than in normal cells. Thus, intracellular targeting using iron-saturated Tf as a ligand for TfR-mediated endocytosis has attracted attention. TfR1 in colon cancer-bearing mice exhibits a 24-hour rhythm in mRNA and protein levels. The clock-controlled gene c-MYC rhythmically activate the transcription of the TfR1 gene. In addition, the cyclical accumulation of TfR1 causes dosing time-dependent changes in the intratumoral delivery of drug by receptor-mediated endocytosis. Identification of the circadian properties of molecules that are targeted by ligand-directed DDS may aid the choice of the most appropriate time of day for their administration.


Subject(s)
Circadian Rhythm/physiology , Receptors, Transferrin/metabolism , Animals , Drug Delivery Systems , Humans , Iron/metabolism , Neoplasms/metabolism , Receptors, Transferrin/genetics , Transferrin/metabolism
12.
Cancer Res ; 70(15): 6238-46, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20631077

ABSTRACT

The abundance of cell surface levels of transferrin receptor 1 (TfR1), which regulates the uptake of iron-bound transferring, correlates with the rate of cell proliferation. Because TfR1 expression is higher in cancer cells than in normal cells, it offers a target for cancer therapy. In this study, we found that the expression of TfR1 in mouse colon cancer cells was affected by the circadian organization of the molecular clock. The core circadian oscillator is composed of an autoregulatory transcription-translation feedback loop, in which CLOCK and BMAL1 are positive regulators and the Period (Per), Cryptochrome (Cry), and Dec genes act as negative regulators. TfR1 in colon cancer-bearing mice exhibited a 24-hour rhythm in mRNA and protein levels. Luciferase reporter analysis and chromatin immunoprecipitation experiments suggested that the clock-controlled gene c-MYC rhythmically activated the transcription of the TfR1 gene. Platinum incorporation into tumor DNA and the antitumor efficacy of transferrin-conjugated liposome-delivered oxaliplatin could be enhanced by drug administration at times when TfR1 expression increased. Our findings suggest that the 24-hour rhythm of TfR1 expression may form an important aspect of strategies for TfR1-targeted cancer therapy.


Subject(s)
Circadian Rhythm/genetics , Colonic Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Proto-Oncogene Proteins c-myc/genetics , Receptors, Transferrin/genetics , Animals , Colonic Neoplasms/drug therapy , Colonic Neoplasms/metabolism , DNA, Neoplasm/metabolism , Genes, myc , Liposomes/administration & dosage , Male , Mice , Mice, Inbred BALB C , Organoplatinum Compounds/administration & dosage , Organoplatinum Compounds/pharmacokinetics , Oxaliplatin , Platinum/pharmacokinetics , Proto-Oncogene Proteins c-myc/biosynthesis , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Receptors, Transferrin/biosynthesis , Transferrin/administration & dosage , Transferrin/pharmacokinetics
13.
Life Sci ; 85(9-10): 372-8, 2009 Aug 26.
Article in English | MEDLINE | ID: mdl-19616563

ABSTRACT

AIMS: Obstructive sleep apnea syndrome (OSAS), characterized by intermittent hypoxia/reoxygenation (IHR), is often associated with changing levels of circulating inflammatory cytokines and causes excessive daytime sleepiness, mood disturbances, and cardiovascular disease. An abnormal rhythm in the expression of circadian clock genes is observed in OSAS patients, and is also implicated in OSAS-related clinical symptoms. IHR-induced signal transduction is thought to underlie OSAS-associated complications. The aim of this study is to elucidate the influence of IHR on signal transduction pathways to inflammatory response and circadian clock regulation. MAIN METHODS: To evaluate the direct action of IHR on intracellular signaling, we used a cell culture model to explore the underlying transcriptional events initiated by IHR. KEY FINDINGS: Treatment of cultured human lung adenocarcinoma epithelial cells (A549) with IHR resulted in the elevation of mRNA levels of an inflammation cytokine interleukin-6 (IL-6), due to activation of the signaling pathway of nuclear factor-kappaB, a potent transcriptional activator of IL-6. On the other hand, the treatment of cells with IHR had little effect on clock gene response element-driven transcription. As a consequence, there was no significant change in mRNA levels of clock genes in IHR-treated cells. SIGNIFICANCE: These results suggest that IHR can activate signal transduction to an inflammatory response, but not to circadian clock regulation. The abnormal rhythm in the expression of clock genes in OSAS patients is attributable to the changed levels of circulating factors that have the ability to modulate clock gene expression.


Subject(s)
Circadian Rhythm/physiology , Hypoxia/physiopathology , Signal Transduction , Adult , Cell Line, Tumor , Circadian Rhythm/genetics , Continuous Positive Airway Pressure , Gene Expression Regulation , Humans , Hypoxia/therapy , Interleukin-6/genetics , Interleukin-6/metabolism , Male , Middle Aged , RNA, Messenger/metabolism , Reference Standards , Reverse Transcriptase Polymerase Chain Reaction , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...